Latest Us Government Procurement News

Page 1 of 1

Island Pharmaceuticals Secures $9M to Propel Galidesivir Toward FDA Approval

Island Pharmaceuticals has raised $9 million to advance its antiviral drug Galidesivir through the FDA’s Animal Rule pathway, targeting inclusion in the US Strategic National Stockpile for biodefense viruses.

Victor Sage

4 Feb 2026

FDA Greenlights Galidesivir’s Animal Rule Pathway, Paving Way for Accelerated Approval

Island Pharmaceuticals secures FDA confirmation on Galidesivir’s development under the Animal Rule, unlocking a streamlined two-stage approval process and significant commercial incentives.

Victor Sage

4 Feb 2026